Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01078350 · ClinicalTrials.gov registry record
Consent for Obtaining Additional Tissue at the Time of a Diagnostic Biopsy
A clinical trial, sponsored by Stanford University.
- Completed
- Registry status
- 93
- Enrollment target
NCT01078350: Completed study, sponsored by Stanford University.
NCT01078350 is a clinical trial that has completed, run by Stanford University. The registered enrollment target is 93 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01078350 has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- 93 participants
- Enrollment target
Study Summary
This study is designed to collect tissue samples that may aid in the treatment and learning about various oncology diagnosis.
Interventions
- PROCEDURE phlebotomy
- PROCEDURE tumor tissue aspiration
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 93 participants |
| Start Date | 2004-05 |
| Est. Completion | 2015-12-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01078350
The ClinicalTrials.gov registry entry for NCT01078350 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 93 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which phlebotomy is the first listed.
NCT01078350 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01078350 about?
NCT01078350 is a clinical study titled "Consent for Obtaining Additional Tissue at the Time of a Diagnostic Biopsy". This study is designed to collect tissue samples that may aid in the treatment and learning about various oncology diagnosis.
What is the current status of trial NCT01078350?
This trial is currently completed. The enrollment target is 93 participants. The study started on 2004-05. Estimated completion is 2015-12-04.
What interventions are being tested in trial NCT01078350?
The interventions under investigation include: phlebotomy (PROCEDURE), tumor tissue aspiration (PROCEDURE).
Who is sponsoring clinical trial NCT01078350?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.